Churchill Capital Corp XI
CCXI · NASDAQ
$10.26−$0.005 (−0.05%)TodayMarket closed ·
Prev close $10.27
About CCXI
- Employees
- 0
- Sector
- N/A
- Industry
- N/A
- Website
- churchillcapital-11.com
Leadership
| Name | Title | Since |
|---|---|---|
| Thomas Schall | — | 1997 |
| Susan Kanaya | — | 2006 |
| Tausif Butt | — | — |
| Rita Jain | — | 2019 |
| Markus Cappel | — | — |
| Thomas Edwards | — | — |
| Joseph Feczko | — | — |
| Jennifer Herron | — | — |
| Geoffrey Parker | — | — |
| James Tyree | — | — |
| David Wheadon | — | — |
| Bill Slattery | — | 2022 |
Suppliers and customers
Price correlation is over one year: 1 means the stocks move together, -1 opposite
| Company | Relationship | Correlation |
|---|---|---|
| Thermo Fisher Scientific TMO | Supplier and customer | 0.80 |
| Vifor Pharma VIFN.SW | Supplier and customer | 0.03 |
| United States | Customer | — |
| Hovione Farmaciencia SA | Supplier and customer | — |
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.